#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Medical News

perimplan stoma

What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?

7. 6. 2024 Source: Dental Care

A Spanish clinical study monitored the effect of administering probiotics as an adjunct therapy to non-surgical mechanical treatment of peri-implantitis. What did the study show regarding the effect on microbiome composition and overall clinical picture when a preparation containing Limosilactobacillus reuteri Prodentis was administered?

dedecek a sestricka

Advances in the Treatment of Myasthenia Gravis on the Horizon

The research of new drugs for the generalized form of myasthenia gravis has made significant progress in recent years. How is the new specific therapy performing? And are we heading towards a radical…
28. 3. 2024 Source: Rare Diseases in Neurology
krev výzkum

Efficacy and Safety of Two Pharmacokinetically-Driven Prophylactic Regimens in People with Hemophilia A

Standard prophylaxis for bleeding in hemophilia A, based on the administration of coagulation factor VIII (FVIII), depends on the patient's weight, the severity of the coagulation factor deficiency,…
20. 2. 2023 Source: Hemophilia
f VIII hemofilie

Critical Overview of Clinical Studies on EHL FVIII Preparations

An international team of experts recently published a comprehensive work evaluating the methodology used in clinical trials of various extended half-life (EHL) factor VIII (FVIII) products. Their…
1. 2. 2023 Source: Hemophilia
gingivitidou

The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis

We summarize the results of a clinical study on the effect of probiotics containing Limosilactobacillus reuteri on the improvement of gingivitis in patients with diabetes. It has been proven that the…
10. 11. 2022 Source: GI, colic and microbiome
výzkum krve

Rurioctocog Alfa Pegol vs. Non-factor Therapy –⁠ Report from Real Clinical Practice

The standard treatment for hemophilia A is the prophylactic administration of coagulation factor VIII (FVIII) concentrate. Recently, some hemophiliacs have also been switched to prophylaxis with…
8. 11. 2022 Source: Hemophilia
hojeni ran 2

The Importance of Hydration in Wound Healing

In response to skin injury, bodily processes initiate to restore the function of the skin barrier, minimize fluid loss, and ensure optimal hydration. Studies have shown that wounds maintained in a…
13. 10. 2022 Source: Wound Healing
medicínská studie 2

Prophylaxis with Rurioctocog Alfa Pegol in Severe Hemophilia A

Rurioctocog alfa pegol represents a modern modality for the treatment of hemophilia from the group of factors with an extended half-life. The authors of a systematic review and meta-analysis…
14. 4. 2022 Source: Hemophilia
starší muž na neurologii

Impact of Prophylaxis on Reducing the Risk of Neurological Problems Associated with Bleeding in Hemophilia A

Bleeding can also cause complications in the nervous system of hemophiliacs. The authors of the work presented below discuss the significance of prophylactic administration of factor VIII coagulation…
14. 4. 2022 Source: Hemophilia
farmakologie farmakokinetika

Pharmacokinetic Comparison of Two EHL Products in Hemophilia A

According to a Canadian study published last year, certain pharmacokinetic differences were observed between two extended half-life factors.
8. 2. 2022 Source: Hemophilia
farmakokinetický protokol krev zkumavky

Practical Two-Point Pharmacokinetic Protocol in Hemophilia A

A recently published study confirmed the practicality of a shortened and simple pharmacokinetic protocol for patients with hemophilia A.
31. 1. 2022 Source: Hemophilia
tablety ilu

Memantine in Dementia Therapy –⁠ Current Findings and Possible Future Applications

Memantine is an inhibitor of NMDA receptors, which are pathologically activated by excessive concentrations of glutamate in the synaptic cleft in Alzheimer's disease. It is indicated in the treatment…
26. 1. 2022 Source: Cognitive in the treatment of Alzheimer's disease
operace_krev

Administration of aPCC as a Prevention of Bleeding After Major Cardiac Surgical Procedures

The possibility of actively preventing severe bleeding after a major cardiac surgical procedure using cardiopulmonary bypass (CPB) by administering a concentrate of activated procoagulant complex…
22. 11. 2021 Source: Hemophilia
kapka krve_ruce

Neutralizing Antibodies Against Emicizumab –⁠ Detailed Analysis Based on a Case Study

Japanese authors investigated the mechanism of reduced efficacy of emicizumab in an adult patient with hemophilia A and an inhibitor, whose treatment was discontinued due to repeated bleeding…
22. 11. 2021 Source: Hemophilia
krvaceni_tepna_zila_krev

Cost-Effectiveness of Preparations Used to Stop Bleeding in Patients with AHA

Choosing the right preparation to manage acute bleeding in patients with acquired hemophilia A is not always simple. An interesting perspective and recommendations are provided by a model analysis…
1. 11. 2021 Source: Hemophilia
1 2 3
Filter by speciality
Remove filters

Popular this week
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#